SABS short interest
SAB Biotherapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 4,291,173 |
|---|---|
| Change vs prior report | 688,108 (+19.1%) |
| Change over six months | +71.3% |
| Days to cover | 4.99 (sector: 3.78) |
| Average daily volume | 860,642 |
| Rank in Healthcare | #418 of 922 by days to cover |
SABS short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 4,291,173 | +19.1% | 4.99 | 860,642 |
| 2026-09-15 | 3,603,065 | -12.6% | 13.37 | 269,533 |
| 2026-08-31 | 4,121,534 | -11.0% | 12.62 | 326,707 |
| 2026-08-14 | 4,630,138 | -0.7% | 11.00 | 420,784 |
| 2026-07-31 | 4,660,515 | +6.5% | 8.95 | 520,581 |
| 2026-07-15 | 4,376,175 | +16.0% | 9.42 | 464,551 |
| 2026-06-30 | 3,773,336 | +31.2% | 2.70 | 1,399,986 |
| 2026-06-15 | 2,876,593 | +8.8% | 3.38 | 851,562 |
| 2026-05-29 | 2,644,665 | -3.7% | 6.67 | 396,248 |
| 2026-05-15 | 2,746,317 | +13.6% | 1.76 | 1,563,731 |
| 2026-04-30 | 2,418,434 | -19.4% | 6.10 | 396,206 |
| 2026-04-15 | 3,000,764 | +19.8% | 6.95 | 431,609 |
| 2026-03-31 | 2,504,815 | +28.2% | 2.98 | 840,769 |
| 2026-03-13 | 1,953,472 | +21.1% | 2.13 | 918,838 |
| 2026-02-27 | 1,613,558 | -13.2% | 5.73 | 281,424 |
| 2026-02-13 | 1,860,014 | -4.4% | 5.77 | 322,185 |
| 2026-01-30 | 1,945,809 | +24.7% | 3.98 | 488,835 |
| 2026-01-15 | 1,559,953 | +7.8% | 3.67 | 425,317 |
| 2025-12-31 | 1,447,052 | +60.5% | 4.87 | 297,129 |
| 2025-12-15 | 901,471 | +28.4% | 3.03 | 297,175 |
| 2025-11-28 | 702,326 | +3.8% | 3.10 | 226,614 |
| 2025-11-14 | 676,534 | -2.9% | 3.62 | 187,053 |
| 2025-10-31 | 696,993 | +0.6% | 2.32 | 300,608 |
| 2025-10-15 | 692,718 | +39.2% | 1.32 | 526,199 |
| 2025-09-30 | 497,544 | +22.8% | 1.14 | 437,862 |
import finzdata as yf
yf.Ticker("SABS").short_interest # every report since 2017
yf.Client().short_interest(["SABS"], start="2018-01-01")Healthcare short interest · SABS price history · Who owns SABS · All short interest